GE Healthcare’s India Strategy Poised to Pay Off

GE Healthcare will launch about 20 new products to be developed in India this year, reports Forbes. The company’s efforts in the country where it spends about US$50 million on R&D annually are finally set to yield results, according to the article titled “GE Healthcare’s India Centre Is a Model of Its Emerging Markets Strategy.”

The company has consistently trumpeted its intent to develop low-cost healthcare solutions that can be applied in emerging markets. GE favoured India as a base over other emerging economies because it is the closest to being a consumer-driven market, notes Forbes, and because R&D costs are low and development times are short.

Tags: GE Healthcare, R&D